Pharmaceutical Industry News | The Pharmaletter
Oct 9, 2024 · Exclusive. Last week’s significant news included Denmark-based CNS drugmaker Lundbeck reaching agreement to acquire US firm Longboard Pharmaceuticals, along with its bexicaserin, for $2.6 billion. Also, US pharma giant Pfizer entered into a deal with TRIANA Biomedicines to develop molecular glue degraders. On the regulatory front, the US Food ...
Pharma, Biotech and Generics Industry News | The Pharmaletter
Oct 15, 2024 · India unleashes Bio-RIDE to spur biotech growth and innovation. 7 October 2024 India's new Biotechnology Research Innovation and Entrepreneurship Development (Bio-RIDE) scheme is a significant step towards consolidating and advancing the country's biotechnology initiative. Pharmaceutical.
Login - The Pharmaletter
6 days ago · The Pharma Letter. 39-43 Putney High Street, Putney London, SW15 1SP United Kingdom
Pharma M&A news | The Pharmaletter
Sep 19, 2024 · Fosun Pharma secures full ownership of Fosun Kite with $27 million deal. Shanghai-based Fosun Pharmaceutical has announced it has acquired the remaining 50% stake in Fosun Kite Biotechnology from Kite Pharma for $27 million, giving it full control of the joint venture. 23 September 2024. Pharmaceutical.
About The Pharma Letter | The Pharmaletter
The Pharma Letter offers high value news and insights for people with a professional interest in the global pharmaceutical, biotech, generic and biosimilar industries. Headquartered in London, the company draws from a network of foreign correspondents, with healthcare journalists around the world providing insight on local markets.
Pharmaceutical Generics Industry News | The Pharmaletter
Sep 5, 2024 · Glenmark pays $25 million fine for generic price-fixing. Glenmark Pharmaceuticals has agreed to pay $25 million, based on its ability to pay, to resolve its alleged liability under the False Claims Act for conspiring to fix the price of a generic drug, the US Department of Justice announced. 5 September 2024. More Generics News >.
Subscribe to The Pharma Letter | The Pharmaletter
Oct 16, 2024 · The Pharma Letter. 39-43 Putney High Street, Putney London, SW15 1SP United Kingdom
MARKETLETTER ON-LINE DAILY - Pharmaceutical industry news
Jun 5, 1994 · Looking at stories daily not only allows subscribers to see what is being published on all aspects of the pharmaceutical industry, it also permits a pre-publication view of what is being said about their own companies; this means it is possible to "add a little more" to what Marketletter is saying. Telephone contacts for Data-Star: UK +44 71 ...
FDA to weigh up Ocaliva approval amid doubts
Sep 12, 2024 · Intercept Pharmaceuticals' Ocaliva (obeticholic acid) will be reviewed by the FDA’s Gastrointestinal Drugs Advisory Committee on Friday regarding its sNDA for use in primary biliary cholangitis (PBC). The submission aims to fulfill post-marketing requirements for reducing risks of death, liver transplant, and hepatic decompensation in adults with PBC without cirrhosis or with compensated ...
Pharma and Biotech Oncology News | The Pharmaletter
6 days ago · The week in pharma: action, reaction and insight – week to October 19. Last week’s significant news included Denmark-based CNS drugmaker Lundbeck reaching agreement to acquire US firm Longboard Pharmaceuticals, along with its bexicaserin, for $2.6 billion. Also, US pharma giant Pfizer entered into a deal with TRIANA Biomedicines to develop ...